{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:56:54Z","timestamp":1791622614466,"version":"4.3.4"},"reference-count":65,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3165,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hum. Psychopharmacol. Clin. Exp."],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1002\/hup.915","type":"journal-article","created":{"date-parts":[[2007,12,20]],"date-time":"2007-12-20T19:16:00Z","timestamp":1198178160000},"page":"S3-S14","source":"Crossref","is-referenced-by-count":146,"title":["Cardiac side effects of psychiatric drugs"],"prefix":"10.1002","volume":"23","author":[{"given":"Paul","family":"Mackin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007]]},"reference":[{"key":"10.1002\/hup.915-BIB1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00004714-200102000-00003","volume":"21","author":"Agelink","year":"2001","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.915-BIB2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/0269881107075509","volume":"21","author":"Barnett","year":"2007","journal-title":"J Psychopharmacol"},{"key":"10.1002\/hup.915-BIB3","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1053\/euhj.2001.2739","volume":"22","author":"Brignole","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1002\/hup.915-BIB4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1192\/bjp.177.3.212","volume":"177","author":"Brown","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1002\/hup.915-BIB5","first-page":"359","volume":"135","author":"Burian","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1002\/hup.915-BIB6","first-page":"82","volume-title":"Cardiovascular Risk Associated With Schizophrenia and its Treatment","author":"Clements-Jewery","year":"2003","unstructured":". 2003. Actions of antipsychotic drugs on ventricular action potential and ion channels. In Cardiovascular Risk Associated With Schizophrenia and its Treatment, 1st edn, (ed.). Galliard Healthcare Communications: London; 82\u2013100."},{"key":"10.1002\/hup.915-BIB7","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/00002826-200103000-00008","volume":"24","author":"Cohen","year":"2001","journal-title":"Clin Neuropharmacol"},{"key":"10.1002\/hup.915-BIB8","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4088\/JCP.v65n0219","volume":"65","author":"Consensus development conference","year":"2004","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.915-BIB9","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1136\/bmj.322.7296.1207","volume":"322","author":"Coulter","year":"2001","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1002\/hup.915-BIB10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4088\/JCP.v62n0310","volume":"62","author":"Czekalla","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.915-BIB11","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/0140-6736(93)90879-L","volume":"341","author":"Day","year":"1993","journal-title":"Lancet"},{"key":"10.1002\/hup.915-BIB12","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/euhj.1998.1276","volume":"20","author":"de Bruyne","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1002\/hup.915-BIB13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00004714-199812000-00011","volume":"18","author":"Drici","year":"1998","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.915-BIB14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1001\/archpsyc.58.9.861","volume":"58","author":"Druss","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/hup.915-BIB15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/01.nmd.0000105996.62105.07","volume":"192","author":"Enger","year":"2004","journal-title":"J Nerv Ment Dis"},{"key":"10.1002\/hup.915-BIB16","author":"FDA","year":"1999","unstructured":"FDA. 1999. Risperdal (risperidone). Revision 2.1-3."},{"key":"10.1002\/hup.915-BIB17","author":"FDA","year":"2001a","unstructured":"FDA. 2001a. Clozaril (clozapine) tablets prescribing information, pp. 1\u201322."},{"key":"10.1002\/hup.915-BIB18","author":"FDA","year":"2001b","unstructured":"FDA. 2001b. FDA Pharmacological Drugs Advisory Committee Briefing Document for Zyprexa Intramuscular (olanzapine for injection). 1\u2013115."},{"key":"10.1002\/hup.915-BIB19","author":"FDA","year":"2001c","unstructured":"FDA. 2001c. Seroquel (quetiapine fumarate) tablets. Revision January 2001, pp. 1\u201325."},{"key":"10.1002\/hup.915-BIB20","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1517\/14740338.4.4.731","volume":"4","author":"Fitzsimons","year":"2005","journal-title":"Expert Opin Drug Saf"},{"key":"10.1002\/hup.915-BIB21","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1177\/070674370605101202","volume":"51","author":"Frasure-Smith","year":"2006","journal-title":"Can J Psychiatry"},{"key":"10.1002\/hup.915-BIB22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.schres.2005.08.010","volume":"80","author":"Goff","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1002\/hup.915-BIB23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0002-9149(91)90099-7","volume":"67","author":"Goldberg","year":"1991","journal-title":"Am J Cardiol"},{"key":"10.1002\/hup.915-BIB24","first-page":"10","volume":"60","author":"Goldman","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.915-BIB25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ahj.2007.01.040","volume":"153","author":"Gupta","year":"2007","journal-title":"Am Heart J"},{"key":"10.1002\/hup.915-BIB26","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00002018-200730010-00005","volume":"30","author":"Haas","year":"2007","journal-title":"Drug Saf"},{"key":"10.1002\/hup.915-BIB27","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0033-3506(01)00471-1","volume":"115","author":"Hannerz","year":"2001","journal-title":"Public Health"},{"key":"10.1002\/hup.915-BIB28","doi-asserted-by":"crossref","first-page":"s149","DOI":"10.1016\/j.euroneuro.2006.06.003","volume":"16","author":"Haupt","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1002\/hup.915-BIB29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/schbul\/22.3.413","volume":"22","author":"Jeste","year":"1996","journal-title":"Schizophr Bull"},{"key":"10.1002\/hup.915-BIB30","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4088\/JCP.v61n0609","volume":"61","author":"Kang","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.915-BIB31","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/S0140-6736(99)10385-4","volume":"354","author":"Killian","year":"1999","journal-title":"Lancet"},{"key":"10.1002\/hup.915-BIB32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002280050626","volume":"55","author":"Kitayama","year":"1999","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1002\/hup.915-BIB33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.7326\/0003-4819-137-6-200209170-00010","volume":"137","author":"Krantz","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1002\/hup.915-BIB34","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1378\/chest.98.2.482","volume":"98","author":"Kriwisky","year":"1990","journal-title":"Chest"},{"key":"10.1002\/hup.915-BIB35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJM200107193450317","volume":"345","author":"La Grenade","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1002\/hup.915-BIB36","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/cvr\/22.1.67","volume":"22","author":"Lau","year":"1988","journal-title":"Cardiovasc Res"},{"key":"10.1002\/hup.915-BIB37","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/BF00754549","volume":"22","author":"Lieberman","year":"1986","journal-title":"Commun Ment Health J"},{"key":"10.1002\/hup.915-BIB38","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.4088\/JCP.v66n1107","volume":"66","author":"Mackin","year":"2005","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.915-BIB39","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00125-004-1641-y","volume":"48","author":"Mackin","year":"2005","journal-title":"Diabetologia"},{"key":"10.1002\/hup.915-BIB40","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1192\/bjp.bp.106.031716","volume":"191","author":"Mackin","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1002\/hup.915-BIB41","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1001\/jama.1993.03510210076031","volume":"270","author":"Makkar","year":"1993","journal-title":"JAMA"},{"key":"10.1002\/hup.915-BIB42","first-page":"101","volume-title":"Cardiovascular Risk Associated With Schizophrenia and its Treatment","author":"Malik","year":"2003","unstructured":"2003. Electrocardiographic aspects of studies investigating drug-related repolarisation changes. In Cardiovascular Risk Associated With Schizophrenia and its Treatment, 1st edn, (ed.). Galliard Healthcare Communication: London; 101\u2013117."},{"key":"10.1002\/hup.915-BIB43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/ajp.147.4.465","volume":"147","author":"Massad","year":"1990","journal-title":"Am J Psychiatry"},{"key":"10.1002\/hup.915-BIB44","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/01.jcp.0000150217.51433.9f","volume":"25","author":"Merrill","year":"2005","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.915-BIB45","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1176\/appi.ajp.163.2.204","volume":"163","author":"Merrill","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1002\/hup.915-BIB46","first-page":"325-397","volume-title":"The Global Burden of Disease","author":"Murray","year":"1996","unstructured":". 1996. Alternative visions of the future: projecting mortality and disability 1990\u20132020. In The Global Burden of Disease, (eds). Harvard University Press: Cambridge (Massachusetts); 325-397."},{"key":"10.1002\/hup.915-BIB47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00023210-200519001-00001","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1002\/hup.915-BIB48","author":"Novartis","year":"2002","unstructured":"Novartis. 2002. Association of Clozaril (clozapine) with cardiovascular toxicity (Dear Healthcare Professional letter)."},{"key":"10.1002\/hup.915-BIB49","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1001\/archpsyc.64.2.242","volume":"64","author":"Osborn","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/hup.915-BIB50","first-page":"690","volume":"8","author":"Rautaharju","year":"1992","journal-title":"Can J Cardiol"},{"key":"10.1002\/hup.915-BIB51","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S0140-6736(00)02035-3","volume":"355","author":"Reilly","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/hup.915-BIB52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1192\/bjp.180.6.515","volume":"180","author":"Reilly","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1002\/hup.915-BIB53","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1176\/appi.ajp.159.9.1607-a","volume":"159","author":"Roesch-Ely","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1002\/hup.915-BIB54","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1161\/01.CIR.84.4.1516","volume":"84","author":"Schouten","year":"1991","journal-title":"Circulation"},{"key":"10.1002\/hup.915-BIB55","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/archpsyc.1997.01830180067009","volume":"54","author":"Small","year":"1997","journal-title":"Arch Gen Psychiatry"},{"key":"10.1002\/hup.915-BIB56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2165\/00002018-200022030-00004","volume":"22","author":"Stanniland","year":"2000","journal-title":"Drug Saf"},{"key":"10.1002\/hup.915-BIB57","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0002-8703(87)90664-8","volume":"113","author":"Stratmann","year":"1987","journal-title":"Am Heart J"},{"key":"10.1002\/hup.915-BIB58","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1034\/j.1600-0447.2003.02078.x","volume":"107","author":"Taylor","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.1002\/hup.915-BIB59","doi-asserted-by":"crossref","first-page":"880","DOI":"10.4088\/JCP.v63n1005","volume":"63","author":"Tham","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1002\/hup.915-BIB60","first-page":"118","volume-title":"Cardiovascular Risk Associated With Schizophrenia and its Treatment","author":"Thomas","year":"2003","unstructured":". 2003. Antipsychotic drug-induced QT interval prolongation. In Cardiovascular Risk Associated With Schizophrenia and its Treatment, 1st edn, (ed.). Galliard Healthcare Communications: London; 118\u2013137."},{"key":"10.1002\/hup.915-BIB61","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-199710000-00010","volume":"17","author":"Tran","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1002\/hup.915-BIB62","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","volume":"93","author":"Warner","year":"1996","journal-title":"Acta Psychiatr Scand"},{"key":"10.1002\/hup.915-BIB63","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0140-6736(05)72452-1","volume":"355","author":"Warner","year":"2000","journal-title":"Lancet"},{"key":"10.1002\/hup.915-BIB64","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/heart.89.11.1363","volume":"89","author":"Yap","year":"2003","journal-title":"Heart (Br Card Soc)"},{"key":"10.1002\/hup.915-BIB65","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.915","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/hup.915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:31:32Z","timestamp":1625164292000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007]]},"references-count":65,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2008,1]]}},"URL":"https:\/\/doi.org\/10.1002\/hup.915","relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007]]}}}